.
.
.
.
Coronavirus

Egypt to purchase 20 million doses of China’s Sinopharm COVID-19 vaccine

Published: Updated:

Egypt has agreed to purchase 20 million doses of the COVID-19 vaccine produced by China’s Sinopharm and expects to receive a batch of 500,000 shots this month, its health ministry said on Tuesday.

Read the latest updates in our dedicated coronavirus section.

The agreement boosts vaccination efforts in Egypt, which has a population of 100 million and has so far received a total of just over 1.5 million doses of Sinopharm and of the AstraZeneca shot.

Earlier this month, Egypt announced it was preparing to produce up to 80 million doses of the vaccine produced by China’s Sinovac.

Read more:

A COVID-19 pivot: How the pandemic pushed people out of jobs and into new careers

US will boost ‘Do Not Travel’ COVID-19 advisory to 80pct of countries worldwide

Scores test positive for COVID-19 on India flight to Hong Kong